SCHEMBL7517596

SCHEMBL7517596

O=C1C=C(Nc2ccccc2)CO1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
SMN1; SMN2 Q16637 5/20 0.44
MAPK1 P28482 4/20 0.44
HSD17B10 Q99714 3/20 0.41
TDP1 Q9NUW8 4/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
TSHR P16473 2/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
PTGS1 P23219 1/20 0.39
SLC6A2 P23975 1/20 0.39
PTGS2 P35354 1/20 0.39
HTR2B P41595 1/20 0.39
KDM4E B2RXH2 2/20 0.38
MAPT P10636 5/20 0.37
LMNA P02545 4/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
HTT P42858 3/20 0.37
NPC1 O15118 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7584252 0.83 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MAPK1TDP1TSHR
SCHEMBL7520380 0.81 MT-CO2 (0.51) ALDH1A1SMN1; SMN2MAPK1PTGS2KDM4E
SCHEMBL7518230 0.81 KDM4E (0.40) ALDH1A1SMN1; SMN2PTGS2KDM4EMAPT
SCHEMBL7515459 0.80 IDO1 (0.43) ALDH1A1CA1EGFR
SCHEMBL7519247 0.78 SMN1; SMN2 (0.55) SMN1; SMN2MAPK1TDP1TSHRKDM4E
SCHEMBL7524044 0.78 KIF11 (0.40) KDM4EMAPTMEN1KMT2ACA1
SCHEMBL7517550 0.78 MAPT (0.50) ALDH1A1SMN1; SMN2MAPK1HSD17B10TDP1
SCHEMBL7520161 0.76 KIF11 (0.52) ALDH1A1SMN1; SMN2MAPTHTTRAB9A
SCHEMBL3036155 0.73 POLB (0.53) ALDH1A1MAPK1HSD17B10L3MBTL1TSHR
SCHEMBL7524238 0.71 RAPGEF4 (0.46) ALDH1A1SMN1; SMN2TDP1L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214009-A2 Enaminones as potential prodrugs of primary and secondary amines MERCK & CO. INC. (US) 1987-03-11 EP claimed
CN-111675715-B Difuranopyridine derivative and preparation method thereof 江苏建筑职业技术学院 2022-10-18 CN disclosed
CN-111675715-A Difuranopyridine derivative and preparation method thereof 江苏建筑职业技术学院 2020-09-18 CN disclosed
EP-1173420-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY Novuspharma S.p.A. (IT) 2002-01-23 EP disclosed
WO-2000053581-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY NOVUSPHARMA S.P.A. (IT) 2000-09-14 WO disclosed
EP-0214009-A2 Enaminones as potential prodrugs of primary and secondary amines MERCK & CO. INC. (US) 1987-03-11 EP disclosed